These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 39252490)

  • 1. Effect of abatacept versus conventional synthetic disease modifying anti-rheumatic drugs on rheumatoid arthritis-associated interstitial lung disease.
    Lee KA; Kim BY; Kim SS; Cheon YH; Lee SI; Kim SH; Jung JH; Kim GT; Hur JW; Lee MS; Kim YS; Hong SJ; Park S; Kim HS
    Korean J Intern Med; 2024 Sep; 39(5):855-864. PubMed ID: 39252490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abatacept in monotherapy vs combined in interstitial lung disease of rheumatoid arthritis-multicentre study of 263 Caucasian patients.
    Fernández-Díaz C; Atienza-Mateo B; Castañeda S; Melero-Gonzalez RB; Ortiz-SanJuan F; Loricera J; Casafont-Solé I; Rodríguez-García S; Aguilera-Cros C; Villa-Blanco I; Raya-Alvarez E; Ojeda-García C; Bonilla G; López-Robles A; Arboleya L; Narváez J; Cervantes E; Maiz O; Alvarez-Rivas MN; Cabezas I; Salgado E; Hidalgo-Calleja C; Fernández S; Fernández JC; Ferraz-Amaro I; González-Gay MA; Blanco R;
    Rheumatology (Oxford); 2021 Dec; 61(1):299-308. PubMed ID: 33779697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients.
    Fernández-Díaz C; Castañeda S; Melero-González RB; Ortiz-Sanjuán F; Juan-Mas A; Carrasco-Cubero C; Casafont-Solé I; Olivé A; Rodríguez-Muguruza S; Almodóvar-González R; Castellanos-Moreira R; Rodríguez-García SC; Aguilera-Cros C; Villa I; Ordóñez-Palau S; Raya-Alvarez E; Morales-Garrido P; Ojeda-García C; Moreno-Ramos MJ; Bonilla Hernán MG; Hernández Rodríguez I; López-Corbeto M; Andreu JL; Jiménez de Aberásturi JRD; Ruibal-Escribano A; Expósito-Molinero R; Pérez-Sandoval T; López-Robles AM; Carreira-Delgado P; Mena-Vázquez N; Urruticoechea-Arana A; Peralta-Ginés C; Arboleya-Rodríguez L; Narváez García FJ; Palma-Sánchez D; Cervantes Pérez EC; Maiz-Alonso O; Alvarez-Rivas MN; Fernández-Melón J; Vela Casasempere P; Cabezas-Rodríguez I; Castellvi-Barranco I; González-Montagut C; Blanco-Madrigal J; Del Val-Del Amo N; Fito MC; Rodríguez-Gómez M; Salgado-Pérez E; García-Magallón B; Hidalgo-Calleja C; López-Sánchez R; Fernández-Aguado S; Fernández-López JC; Castro-Oreiro S; Serrano-García I; García-Valle A; Romero-Yuste S; Expósito-Pérez L; Pérez-Albadalejo L; García-Aparicio A; Quillis-Marti N; Bernal-Vidal JA; Loricera-García J; Hernández JL; González-Gay MA; Blanco R
    Rheumatology (Oxford); 2020 Dec; 59(12):3906-3916. PubMed ID: 33068439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients.
    Fernández-Díaz C; Loricera J; Castañeda S; López-Mejías R; Ojeda-García C; Olivé A; Rodríguez-Muguruza S; Carreira PE; Pérez-Sandoval T; Retuerto M; Cervantes-Pérez EC; Flores-Robles BJ; Hernández-Cruz B; Urruticoechea A; Maíz-Alonso O; Arboleya L; Bonilla G; Hernández-Rodríguez Í; Palma D; Delgado C; Expósito-Molinero R; Ruibal-Escribano A; Álvarez-Rodríguez B; Blanco-Madrigal J; Bernal JA; Vela-Casasempere P; Rodríguez-Gómez M; Fito C; Ortiz-Sanjuán F; Narváez J; Moreno M; López-Corbeto M; Mena-Vázquez N; Aguilera-Cros C; Romero-Yuste S; Ordóñez S; Villa-Blanco I; Gonzélez-Vela MC; Mora-Cuesta V; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
    Semin Arthritis Rheum; 2018 Aug; 48(1):22-27. PubMed ID: 29422324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression.
    Tardella M; Di Carlo M; Carotti M; Giovagnoni A; Salaffi F
    Clin Rheumatol; 2021 Dec; 40(12):4861-4867. PubMed ID: 34313866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review.
    Vicente-Rabaneda EF; Atienza-Mateo B; Blanco R; Cavagna L; Ancochea J; Castañeda S; González-Gay MÁ
    Autoimmun Rev; 2021 Jun; 20(6):102830. PubMed ID: 33887489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis.
    Kurata I; Tsuboi H; Terasaki M; Shimizu M; Toko H; Honda F; Ohyama A; Yagishita M; Osada A; Ebe H; Kawaguchi H; Takahashi H; Hagiwara S; Asashima H; Kondo Y; Matsumoto I; Sumida T
    Intern Med; 2019 Jun; 58(12):1703-1712. PubMed ID: 30799358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term deterioration of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept.
    Mochizuki T; Ikari K; Yano K; Sato M; Okazaki K
    Mod Rheumatol; 2019 May; 29(3):413-417. PubMed ID: 29798700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients.
    López-Maraver M; Serrano-Combarro A; Atienza-Mateo B; Del Val N; Casafont-Solé I; Melero-Gonzalez RB; Pérez-Linaza A; Calvo Gutiérrez J; Mena-Vázquez N; Vegas-Revenga N; Domínguez-Casas L; Loarce Martos J; Peralta Ginés CA; Diez Morrondo C; Pérez Albaladejo L; López Sánchez R; Manzano Canabal MG; Brandy-García AM; López Viejo P; Bonilla G; Maiz-Alonso O; Carrasco-Cubero C; Garijo Bufort M; Moreno M; Urruticoechea-Arana A; Ordóñez-Palau S; González-Montagut C; Giner Serret E; De Dios Jiménez De Aberasturi JR; Lozano Morillo F; Vázquez Rodríguez T; Carreira PE; Blanco Madrigal JM; Miguel Ibáñez B; Rodríguez López M; Fernández-Díaz C; Loricera J; Ferraz-Amaro I; Ferrer-Pargada D; Castañeda S; Blanco R;
    Semin Arthritis Rheum; 2024 Oct; 68():152517. PubMed ID: 39067148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-anti-TNF biologic agents are associated with slower worsening of interstitial lung disease secondary to rheumatoid arthritis.
    Mena-Vázquez N; Godoy-Navarrete FJ; Manrique-Arija S; Aguilar-Hurtado MC; Romero-Barco CM; Ureña-Garnica I; Espildora F; Añón-Oñate I; Pérez-Albaladejo L; Gomez-Cano C; Jimenez-Núñez FG; Padin-Martín MI; Fernández-Nebro A
    Clin Rheumatol; 2021 Jan; 40(1):133-142. PubMed ID: 32557255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of the efficacy of JAK inhibitors or abatacept on rheumatoid arthritis-interstitial lung disease.
    Tardella M; Di Carlo M; Carotti M; Ceccarelli L; Giovagnoni A; Salaffi F
    Inflammopharmacology; 2022 Jun; 30(3):705-712. PubMed ID: 35462572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: data from an observational study.
    Ozen G; Pedro S; Schumacher R; Simon TA; Michaud K
    Arthritis Res Ther; 2019 Jun; 21(1):141. PubMed ID: 31174592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iguratimod attenuates general disease activity and improves lung function in rheumatoid arthritis-associated interstitial lung disease patients.
    Shu P; Shao SQ; Cai XN; Zhou DM; Ma H; Lu L; Yin HQ; Yin SL
    Eur Rev Med Pharmacol Sci; 2021 Jul; 25(14):4687-4692. PubMed ID: 34337716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Mena-Vázquez N; Rojas-Gimenez M; Fuego-Varela C; García-Studer A; Perez-Gómez N; Romero-Barco CM; Godoy-Navarrete FJ; Manrique-Arija S; Gandía-Martínez M; Calvo-Gutiérrez J; Morales-Garrido P; Mouriño-Rodriguez C; Castro-Pérez P; Añón-Oñate I; Espildora F; Aguilar-Hurtado MC; Hidalgo Conde A; Arnedo Díez de Los Ríos R; Cabrera César E; Redondo-Rodriguez R; Velloso-Feijoo ML; Fernández-Nebro A
    Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis.
    Nakashita T; Ando K; Kaneko N; Takahashi K; Motojima S
    BMJ Open; 2014 Aug; 4(8):e005615. PubMed ID: 25125479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Interstitial Lung Disease in Patients With Rheumatoid Arthritis Treated With Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs.
    Baker MC; Liu Y; Lu R; Lin J; Melehani J; Robinson WH
    JAMA Netw Open; 2023 Mar; 6(3):e233640. PubMed ID: 36939701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiological evaluation of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept or JAK inhibitors for 1 year.
    Mochizuki T; Yano K; Ikari K; Okazaki K
    Respir Investig; 2023 May; 61(3):359-363. PubMed ID: 37031622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of imaging findings, laboratory and functional parameters in rheumatoid arthritis patients after one year of treatment with anti-TNF-α agents.
    Detorakis EE; Magkanas E; Lasithiotaki I; Sidiropoulos P; Boumpas DT; Gourtsoyiannis N; Antoniou K; Raissaki M
    Clin Exp Rheumatol; 2017; 35(1):43-52. PubMed ID: 27908307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abatacept versus tumor necrosis factor inhibitors on mortality and medical utilizations in the treatment of rheumatoid arthritis associated interstitial lung disease: a large-scale real-world retrospective cohort study.
    Shih PC; Lai CC; Zou QH; Wang SI; Huang XY; Wei JCC
    Clin Exp Med; 2024 Aug; 24(1):186. PubMed ID: 39133368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abatacept in usual and in non-specific interstitial pneumonia associated with rheumatoid arthritis.
    Atienza-Mateo B; Fernández-Díaz C; Vicente-Rabaneda EF; Melero-González RB; Ortiz-Sanjuán F; Casafont-Solé I; Rodríguez-García SC; Ferraz-Amaro I; Castañeda S; Blanco R;
    Eur J Intern Med; 2024 Jan; 119():118-124. PubMed ID: 37673775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.